INSM Price Targets and Analyst Ratings NASDAQ:INSM
INSM Forecast. What You Should Know.
INSM Historical Ratings and Targets
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.